Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?-Reference-Cited by-同舟云学术

Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?

Published:2017-08-28 Issue:11 Volume:21 Page:1793-1803
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Barnes Chad A.,Krepline Ashley N.,Aldakkak Mohammed,Clarke Callisia N.,Christians Kathleen K.,Khan Abdul H.,Hunt Bryan C.,Ritch Paul S.,George Ben,Hall William A.,Erickson Beth A.,Evans Douglas B.,Tsai Susan

Funder

We Care Fund for Medical Innovation

Ronald Burklund Eich Pancreatic Cancer Research Fund

Advancing a Healthier Wisconsin

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/article/10.1007/s11605-017-3544-5/fulltext.html

Reference27 articles.

1. Sohal DP, Walsh RM, Ramanathan RK, Khorana AA. Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy. Journal of the National Cancer Institute. 2014;106(3):dju011.

2. Pancreatic adenocarcinoma 2017 [updated version 1.2017–February 24, 2017. Available from: http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf .

3. Merkow RP, Bilimoria KY, Tomlinson JS, Paruch JL, Fleming JB, Talamonti MS, et al. Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Annals of surgery. 2014;260(2):372–7.

4. Wu W, He J, Cameron JL, Makary M, Soares K, Ahuja N, et al. The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma. Annals of surgical oncology. 2014;21(9):2873–81.

5. Tsai S, Erickson BA, Dua K, Ritch PS, Tolat P, Evans DB. Evolution of the management of resectable pancreatic cancer. J Oncol Pract. 2016;12(9):772–8.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi‐institutional analysis;Journal of Surgical Oncology;2024-08-21

2. Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy;Pancreatology;2024-08

3. Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX;Cancer Research and Treatment;2023-07-15

4. Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study;International Journal of Surgery;2023-07-06

5. Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study;MedComm;2023-02-19